Page last updated: 2024-10-27

2,5-dihydroxybenzoic acid and Leukemia

2,5-dihydroxybenzoic acid has been researched along with Leukemia in 1 studies

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, MS1
Kalyanaraman, B1
Feix, JB1

Other Studies

1 other study available for 2,5-dihydroxybenzoic acid and Leukemia

ArticleYear
Enhancement of merocyanine 540-mediated phototherapy by salicylate.
    Cancer research, 1993, Feb-15, Volume: 53, Issue:4

    Topics: Animals; Cell Survival; Drug Synergism; Gentisates; Humans; Hydroxides; Hydroxybenzoates; Hydroxyl R

1993